Brief: Sino Biopharmaceutical Disposes Of 55% Equity Interest In Suzhou Tianqing Xingwei Medicines
08/11/2023 15:13
Nov 8 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* DISPOSED OF 55% EQUITY INTEREST IN SUZHOU TIANQING XINGWEI
MEDICINES, AMONG OTHERS AT VALUATION OF RMB210 MILLION
* TOTAL SALE PROCEEDS OF DISPOSAL RMB150 MILLION
Source text for Eikon: ID:nHKS9xLxdN
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up